| DIRECT COMPETITOR COMPARISON | |
| TCM | AOB | Pvt1 | Pvt2 | Industry | | Market Cap: | 119.51M | 339.91M | N/A | N/A | 98.96M | | Employees: | 1,670 | 4,076 | 2501 | 2,4111 | 65 | | Qtrly Rev Growth (yoy): | -5.30% | 11.70% | N/A | N/A | 19.10% | | Revenue (ttm): | N/A | 292.39M | 60.70M1 | 2.41B1 | 13.84M | | Gross Margin (ttm): | 59.68% | 59.34% | N/A | N/A | 65.67% | | EBITDA (ttm): | N/A | 79.82M | N/A | N/A | -12.25M | | Oper Margins (ttm): | N/A | 23.16% | N/A | N/A | -149.46% | | Net Income (ttm): | N/A | 37.58M | N/A | 18.90M1 | N/A | | EPS (ttm): | N/A | 0.494 | N/A | N/A | -0.31 | | P/E (ttm): | N/A | 8.79 | N/A | N/A | 17.51 | | PEG (5 yr expected): | 2.45 | 0.99 | N/A | N/A | 1.28 | | P/S (ttm): | N/A | 1.16 | N/A | N/A | 10.12 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 57.35 | 0.23% | 58.05B | 12.51 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 52.16 | -0.31% | 15.08B | 17.46 | | Genzyme Corp. | GENZ | 48.20 | -0.21% | 12.79B | 27.48 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.01 | -0.53% | 38.71B | 16.63 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.82 | 0.19% | 9.24B | 1057.55 | | Teva Pharmaceutical Industries Limited | TEVA | 55.98 | 0.34% | 49.32B | 51.22 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 39.80 | 1.97% | 4.22B | 20.52 | | King Pharmaceuticals Inc. | KG | 12.24 | -0.33% | 3.04B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.74 | -0.79% | 5.73B | 114.97 | | Pfizer Inc. | PFE | 18.58 | -0.16% | 149.93B | 15.43 | | Johnson & Johnson | JNJ | 64.57 | 0.06% | 178.16B | 14.10 | | GlaxoSmithKline plc | GSK | 42.09 | -0.52% | 106.70B | 13.71 | | Sanofi-Aventis | SNY | 39.70 | 0.71% | 103.66B | N/A | | Novartis AG | NVS | 54.60 | 0.70% | 124.01B | 16.35 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 42.80 | 0.23% | N/A | N/A | | AstraZeneca plc | AZN | 45.97 | -0.22% | 66.66B | 9.23 | | Abbott Laboratories | ABT | 54.09 | -0.06% | 83.66B | 14.65 | | Bristol-Myers Squibb Co. | BMY | 25.70 | 0.43% | 50.91B | 13.30 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|